Eurofins Bioanalytical Services expands its technology footprint with the 25 fluorescent channel Novocyte QuanteonTM Flow Cytometer.
Expert Interview
In this Bioanalysis Zone interview, David Lanham of Eurofins BioPharma Services discusses flow cytometry for pharmacodynamic biomarker analysis and receptor engagement in early clinical stage work. David also explains the challenges faced when using flow cytometry as an analytical tool, before sharing his thoughts on the progress that has been made to regulate and standardize the field.
0 Comments Click here to read/write comments
Tags: Bioanalytical Testing, BioPharma, Leadership, Flow Cytometry, Biomarker Analysis, Receptor Engagement
